FSCN‑1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition.
about
FSCN‑1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@en
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@nl
type
label
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@en
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@nl
prefLabel
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@en
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@nl
P2093
P2860
P356
P1476
FSCN‑1 increases doxorubicin r ...... helial-mesenchymal transition.
@en
P2093
Chengwu Zhang
Dongsheng Huang
Weiding Wu
Weifeng Yao
Yuanbiao Zhang
Yuhua Zhang
P2860
P356
10.3892/IJO.2018.4327
P577
2018-03-20T00:00:00Z